Casado V - Search Results

1

Interferon-beta1b in multiple sclerosis: effect on progression of disability and clinical markers of treatment response.

Carmona O, Casado V, Moral E, Alonso-Magdalena L, Martínez-Yélamos A, Martínez-Yélamos S, Martín-Ozaeta G, Arbizu T. Carmona O, et al. Among authors: casado v. Eur Neurol. 2008;60(6):279-84. doi: 10.1159/000157881. Epub 2008 Sep 27. Eur Neurol. 2008. PMID: 18824855 Clinical Trial.

2

Apolipoprotein alleles and the response to interferon-β-1b in multiple sclerosis.

Carmona O, Masuet C, Alía P, Moral E, Alonso-Magdalena L, Casado V, Martín-Ozaeta G, Arbizu T. Carmona O, et al. Among authors: casado v. Eur Neurol. 2011;65(3):132-7. doi: 10.1159/000323982. Epub 2011 Feb 12. Eur Neurol. 2011. PMID: 21325856

3

Regression to the mean in multiple sclerosis.

Martínez-Yélamos S, Martínez-Yélamos A, Martín Ozaeta G, Casado V, Carmona O, Arbizu T. Martínez-Yélamos S, et al. Among authors: casado v. Mult Scler. 2006 Dec;12(6):826-9. doi: 10.1177/1352458506070820. Mult Scler. 2006. PMID: 17263014

4

Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability.

Casado V, Martínez-Yélamos S, Martínez-Yélamos A, Carmona O, Alonso L, Romero L, Moral E, Gubieras L, Arbizu T. Casado V, et al. BMC Health Serv Res. 2006 Nov 1;6:143. doi: 10.1186/1472-6963-6-143. BMC Health Serv Res. 2006. PMID: 17078879 Free PMC article.

5

14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis.

Martínez-Yélamos A, Saiz A, Sanchez-Valle R, Casado V, Ramón JM, Graus F, Arbizu T. Martínez-Yélamos A, et al. Among authors: casado v. Neurology. 2001 Aug 28;57(4):722-4. doi: 10.1212/wnl.57.4.722. Neurology. 2001. PMID: 11524491 Free article.

6

[The costs of a multiple sclerosis relapse in Catalonia (Spain)].

Casado V, Martinez-Yelamos S, Martinez-Yelamos A, Carmona O, Alonso L, Romero L, Moral E, Arbizu T. Casado V, et al. Neurologia. 2006 Sep;21(7):341-7. Neurologia. 2006. PMID: 16977554 Spanish.

7

An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain.

Casado V, Romero L, Gubieras L, Alonso L, Moral E, Martinez-Yelamos S, Martinez-Yelamos A, Carmona O, Arbizu T. Casado V, et al. Mult Scler. 2007 Jul;13(6):800-4. doi: 10.1177/1352458506073480. Epub 2007 Mar 15. Mult Scler. 2007. PMID: 17613609

8

[Interferon-beta and autoinmune hepatitis in multiple sclerosis: cause-effect or association?].

Carmona O, Gubieras L, Romero-Pinel L, Alonso-Magdalena L, Moral E, Casado V, Arbizu T. Carmona O, et al. Among authors: casado v. Neurologia. 2008 Sep;23(7):468-9. Neurologia. 2008. PMID: 18726728 Spanish. No abstract available.

9

Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker?

Carmona O, Masuet C, Santiago O, Alía P, Moral E, Alonso-Magdalena L, Casado V, Arbizu T. Carmona O, et al. Among authors: casado v. Acta Neurol Scand. 2011 Oct;124(4):258-63. doi: 10.1111/j.1600-0404.2010.01473.x. Epub 2011 Jan 6. Acta Neurol Scand. 2011. PMID: 21208197

10

Specificity of frontal dysfunctions in relapsing-remitting multiple sclerosis.

Santiago O, Guàrdia J, Casado V, Carmona O, Arbizu T. Santiago O, et al. Among authors: casado v. Arch Clin Neuropsychol. 2007 Jun;22(5):623-9. doi: 10.1016/j.acn.2007.04.003. Epub 2007 May 7. Arch Clin Neuropsychol. 2007. PMID: 17482795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters